ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1433	National Cancer Institute	Html	en	Genetics of Breast and Gynecologic Cancers (PDQ®)–Health Professional Version	Expert-reviewed information summary about the genetics of breast and gynecologic cancers, including information about specific genes and family cancer syndromes. The summary also contains information about interventions that may influence the risk of developing breast and gynecologic cancers in individuals who may be genetically susceptible to these diseases. Psychosocial issues associated with genetic testing are also discussed.	Pregnancy-associated breast cancer 0.506333 total breast cancer 0.488298 primary breast cancer 0.498056 BRCA1 pathogenic variants 0.493823 Prospective breast cancer 0.487994 Br J Cancer 0.484038 Int J Cancer 0.495039 individual breast cancer 0.489704 cancer risk reduction 0.475227 triple-negative breast cancer 0.516988 breast cancer decline 0.488175 ovarian cancer 0.654478 breast cancer patients 0.493005 postmenopausal breast cancer 0.500017 breast cancer risk. 0.510237 cancer risk assessment 0.501046 Natl Cancer Inst 0.80311 Ovarian Cancer Group 0.476381 BRCA1-associated breast cancer 0.507407 invasive breast cancer 0.506617 endometrial cancer 0.505116 hormone replacement therapy 0.500252 breast cancer prediction 0.489793 et al. 0.567541 BRCA2 mutation carriers 0.531322	women 0.515983 contralateral breast cancer 0.498075 early breast cancer 0.50631 early-onset breast cancer 0.489583 nonpolyposis colorectal cancer 0.483231 breast cancer family 0.518542 breast cancer diagnosis 0.495632 BOADICEA breast cancer 0.48834 PUBMED Abstract 0.498618 pathogenic variants 0.552407 Cancer Res Treat 0.576792 Breast Cancer Treatment 0.508531 epithelial ovarian cancer 0.48165 ovarian cancer risk 0.536184 breast cancer risk 0.765155 Abstract 0.613814 breast cancer survival 0.499805 breast cancer 0.946746 breast cancer mortality 0.506691 Breast cancer cluster 0.487434 family history 0.570688 breast cancer incidence 0.492239 familial breast cancer 0.49066 Breast Cancer Res 0.640001	CLICK HERE
1452	National Cancer Institute	Html	en	Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Health Professional Version	Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.	smoking cessation strategy 0.633721 smoking cessation rates 0.605741 quit attempt 0.552085 effective smoking cessation 0.580922 gradual cessation group 0.483049 abrupt cessation 0.562882 prolonged validated smoking 0.480554 lung cancer 0.658405 tobacco cessation 0.463262 smoking cessation pharmacotherapies 0.597527 abrupt smoking cessation 0.601297 pipe tobacco smoking 0.505275 current smoking 0.475722 gradual cessation arm 0.465437 nicotine replacement therapy 0.54532 randomized trial 0.492165 Smoking cessation counseling 0.609156 receptor partial agonist 0.460896 area-level smoking prevalence 0.513667 smoking reduction 0.49426 smoking behavior 0.469981 smoking cessation treatment 0.588411 smoking prevalence data 0.513642 tobacco products 0.485537	abrupt cessation arm 0.472163 smoking cessation 0.926558 vs abrupt cessation 0.475821 adult cigarette smoking 0.474818 gradual cessation method 0.466403 cigarette smoking cessation 0.573293 cigarette smoking 0.62168 smoking cessation pharmacotherapy 0.595082 varenicline 0.542592 tobacco smoking 0.505702 smoking cessation rate. 0.602815 gradual cessation 0.501212 abrupt cessation group 0.489713 nicotinic acetylcholine receptor 0.464069 self-reported smoking abstinence 0.502629 smoking abstinence 0.574891 cigarette smoking prevalence 0.566333 randomized controlled trial 0.482431 6-month cessation rates 0.474432 nicotine patch 0.531368 smoking cessation intervention 0.590903 usual smoking patterns 0.480697 lung cancer mortality 0.510576 varenicline group 0.534998	CLICK HERE
1535	National Cancer Institute	Html	en	Hydrazine Sulfate (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of hydrazine sulfate as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	single agent 0.446847 measurable tumor regression 0.444265 hydrazine sulfate group 0.561221 stable disease 0.438607 hydrazine sulfate therapy. 0.512358 advanced nonsmall cell 0.439337 body weight 0.435692 prostate cancer tumors 0.435725 best tumor responses 0.433645 anticancer treatment 0.440366 white blood cells 0.437041 bladder cancer tumors 0.452946 clinical trials 0.508473 cancer information summary 0.434117 clinical drug research 0.432809 placebo group 0.446705 patients 0.531553 FBCa bladder cancer 0.447874 cancer patients 0.442585 hydrazine sulfate therapy 0.539457 complete responses 0.433235 multiple-drug chemotherapy regimen 0.457646 breakdown products 0.436734 human tumor cells 0.434705 radiation therapy 0.432799	anticancer activity 0.483124 hydrazine sulfate research 0.543056 treatment 0.474001 United States 0.450385 hydrazine sulfate administration 0.532876 National Toxicology Program 0.441282 nonsmall cell lung 0.4545 clinical series 0.445474 hydrazine compounds 0.479897 hydrazine analogs 0.451642 National Cancer Institute 0.447177 tumor growth 0.446716 partial responses 0.440765 Cancer Treatment Group 0.438635 hydrazine sulfate blocks 0.527938 hydrazine antidepressants 0.434523 enhanced antitumor activity 0.43882 advanced cancer 0.436974 animal studies 0.436395 hydrazine sulfate 0.995392 Hydrazine administration 0.434303 cell lung cancer 0.443379 objective tumor response 0.459617 clinical studies 0.444539	CLICK HERE
1643	National Cancer Institute	Html	en	Mistletoe Extracts (PDQ®)–Patient Version	Mistletoe extracts have been studied in Europe as a treatment for many illness including cancer. Read about the use of mistletoe therapy in cancer patients and the results of clinical trials in this expert-reviewed summary.	cancer treatment 0.498733 mistletoe extracts 0.84177 European mistletoe species 0.59742 cancer cell growth 0.480977 Cancer Complementary 0.499093 white blood cells 0.478127 clinical trials 0.814026 injectable mistletoe extracts 0.584449 cancer information summary 0.547122 alternative cancer therapies 0.496047 National Center 0.487589 CAM cancer research 0.482862 mistletoe extract products 0.586898 patients 0.558663 cancer patients 0.50887 body fight cancer 0.488697 certain European countries 0.486934 mistletoe 0.936372 Integrative Health 0.4867 NCI PDQ cancer 0.515414 alternative medicine therapies 0.509636 cancer information database 0.494234 randomized clinical trials 0.496538 Therapies Editorial Board 0.492111	metastatic pancreatic cancer 0.479516 mistletoe plant 0.574134 injectable mistletoe 0.604199 treatment 0.516928 Complementary Therapies Editorial 0.512225 human cancer cells 0.481784 Drug Administration 0.544399 Cancer Information Specialist 0.48946 cancer cells 0.492698 PDQ cancer information 0.630287 Cancer Information Service 0.543474 mistletoe extract 0.769423 mistletoe dose 0.56553 treatment clinical trials 0.481986 National Cancer Institute 0.675985 studies 0.476699 alternative medicine 0.586786 European mistletoe 0.657219 mistletoe products 0.583934 mistletoe lectins 0.572067 cancer clinical trials 0.506662 cell lung cancer 0.478767 alternative therapies 0.505915 cancer information summaries 0.526674	CLICK HERE
1682	National Cancer Institute	Html	en	Family Caregivers in Cancer: Roles and Challenges (PDQ®)–Health Professional Version	Expert-reviewed information summary about the challenges faced by family caregivers of cancer patients. This summary focuses on typical caregiver roles and concerns, and helpful interventions for caregivers.	caregiver strain 0.637562 caregiver self-efficacy 0.583778 caregiver involvement 0.610915 cancer care facility 0.578352 palliative care consultation 0.608288 caregiver knowledge 0.586068 Hispanic caregivers 0.676204 caregiver 0.821035 Caregiver quality 0.603509 white caregivers 0.639176 health care providers 0.59721 specialist-level palliative care 0.56948 caregiver well-being 0.592799 patient symptom care 0.583377 culturally competent care 0.564531 patients 0.715455 cancer patients 0.703941 Asian American caregivers 0.689382 caregiver emotional health 0.625075 secondary informal caregivers 0.653486 caregiver burden 0.63516 caregiver’s information 0.595277 symptom management 0.696609 orient caregivers 0.633121 primary caregiver 0.613245	caregiver portion 0.581896 African American caregivers 0.664952 caregiver needs 0.592313 end-of-life care 0.586635 family caregivers 0.726566 study 0.578902 problem-solving intervention 0.564815 bereaved caregivers 0.642182 palliative care 0.6279 tailored caregiver interventions. 0.613747 African American patients 0.595756 caregivers 0.977146 terminally ill patients 0.564522 studies 0.568233 empowers caregivers 0.628512 caregiver roles 0.620453 minority caregivers 0.663649 emotional support 0.572233 home care workers 0.567134 Caregivers report 0.630818 Caregiver assessment 0.592589 family caregiver 0.60516 cancer patient 0.576832 difficult caregiver responsibilities 0.601191	CLICK HERE
1790	National Cancer Institute	Html	es	Trastornos del sueño (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y manejo de los trastornos del sueño en las personas con cáncer.	menudo causa problemas 0.738807 TCC ayuda 0.533662 pequeño número 0.542064 siguientes aspectos 0.690699 siguientes elementos 0.547894 leucemia linfocítica aguda 0.539982 sudores nocturnos 0.6269 siguientes cambios 0.544948 menor número 0.522208 Frecuencia respiratoria 0.534403 fase monr 0.549571 salud afectarán 0.52618 National Cancer Institute 0.522679	sueño mejora 0.68532 siguientes riesgos 0.520223 sueño mor 0.930755 Instituto Nacional 0.543079 siguientes problemas 0.588617 siguientes funciones 0.571878 Physician Data Query 0.591028 fase mor 0.552867 PDQ Trastornos 0.547079 auto hipnosis 0.530427 numerosas razones 0.546303 solo relajarme 0.534672	CLICK HERE
2105	National Cancer Institute	Html	es	Exámenes de detección del cáncer de endometrio (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de endometrio.	Surgical Adjuvant Breast 0.318516 Obstet Gynecol 0.462808 endometrial neoplasia 0.330318 endometrial carcinoma 0.35462 mujeres asintomáticas conducirán 0.327753 endometrial biopsy 0.375747 Society Cancer Detection 0.324775 Sin embargo 0.322994 American Cancer Society 0.532275 Barakat RR 0.322448 postmenopausal estrogen 0.311047 Hereditary nonpolyposis colon 0.316803 Cancer Society Guidelines 0.326353 mutation analysis 0.309345 CA Cancer 0.344524 ecografía transvaginal 0.32543 Instituto Nacional 0.316776 PDQ Exámenes 0.310268 Natl Cancer Inst 0.409601 Vasen HF 0.314679 Bowel Project P-1 0.314149 Survival analysis 0.309166 endometrial thickness 0.328405 Gynecol Oncol 0.319248 patients with 0.312917	endometrial cancer 0.986652 Endometrial morphology 0.328059 Genetics Studies Consortium 0.313592 Cancer Facts 0.328027 Cancer risk 0.385512 with endometrial biopsy 0.334209 mutation carriers 0.308983 Cancer Survival Study 0.330775 hereditary nonpolyposis 0.373835 National Cancer Institute 0.323419 endometrial biopsy specimens 0.329768 replacement therapy 0.315579 postmenopausal women 0.352328 Clin Oncol 0.321066 Gynaecol Obstet 0.310774 PDQ Genetics 0.309874 mujeres portadoras 0.322212 adjuvant breast 0.320298 ecografía endovaginal 0.333573 endometrial abnormalities 0.37706 National Surgical Adjuvant 0.314342 Ultrasound Obstet Gynecol 0.310185 mujeres morirán 0.321645 Mecklin JP 0.317214	CLICK HERE
3580	National Cancer Institute	Html	en	Cancer Genomics Research	Investigating the genetic foundations of cancer has improved our understanding of cancer biology and led to better prevention, diagnosis and treatment methods.	potential cancer genes 0.58754 multiple genomic techniques 0.659582 previous genomic studies 0.697319 cancer genomics 0.705134 clinical trials 0.615766 genomic data 0.812653 Genomic tools 0.615952 genomic signatures 0.587963 genomic characterization 0.591197 NCI’s Division 0.582338 genomic information 0.620002 genomic changes 0.698716 Genomic Data Commons 0.677909 NCI-generated genomic datasets 0.64782 standard cancer treatments 0.600357 cancer genome 0.653485 nci genomic data 0.792126 rare cancer subtypes 0.618402 human cancer 0.596543 cancers 0.577123 cancer genomes 0.733233 Cancer Driver Discovery 0.592638 Human Models Cancer 0.601 genomic basis 0.598972 cancer genomic data 0.759195	raw genomic data 0.677768 new cancer models 0.609201 cancer cells 0.581921 cancer genome studies 0.638148 cancer cell lines 0.586373 cancer genomics research 0.701055 initial genomic discoveries 0.63816 Cancer Genome Characterization 0.60378 lung cancer trials 0.58967 genomic subtypes 0.604215 studies cancer genomes 0.636536 Cancer Genomics Cloud 0.591583 genetic alterations 0.63917 Cancer Genome Atlas 0.60256 cancer development 0.593441 genomic insights 0.591156 DCEG Cancer Genomics 0.589882 diverse cancer genomics 0.601997 genomic methods 0.620776 genomic traits 0.649401 genomic studies 0.746705 cancer 0.914614 genomic data sharing 0.682873 Cancer Treatment Discovery 0.59833	CLICK HERE
15802	National Cancer Institute	Html	null	About the Blue Ribbon Panel	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.			CLICK HERE
16825	National Cancer Institute	Html	en	NCI's Genome Characterization Pipeline	The Genome Characterization Pipeline, run by NCI’s Center for Cancer Genomics, transforms cancer tissue samples into rich genomic datasets that are shared with the research community.	DNA mutation drivers 0.542472 CCG Genomic Data 0.762494 collaborative effort 0.483957 GDC 0.485667 standardized workflow 0.488583 clinical data 0.512601 Working Groups 0.474461 future research 0.474579 Nationwide Children 0.482385 clinical trials 0.4849 Data Analysis Network 0.766186 big data 0.506113 Genomic Data Commons 0.920724 rich data 0.497819 normal tissue 0.486161 CCG pipeline 0.580522 clinical datasets 0.491928 BCR 0.476542 genomic characterization techniques 0.643779 multi-omics data 0.504906 community oncology groups 0.554099 NCI’s Center 0.495612 diverse team 0.474615 expandable data sharing 0.563688 wide range 0.476766	facilitate precision oncology 0.534807 cancer research community 0.569169 United States 0.565759 CCG’s Analysis 0.590169 Tumor tissues 0.508861 Hospital processes 0.481423 rigorous quality standards 0.551886 CCG’s Genomic 0.671044 Data Access Processes 0.55821 Genome Characterization Centers 0.857246 Genome Characterization Pipeline 0.608208 CCG studies 0.604302 GDAN shares 0.480133 raw output 0.475322 CCG partners 0.607468 tumor tissue samples 0.559731 research teams 0.490873 CCG 0.76836 rich cancer 0.489758 Cancer Genomics 0.492347 novel analyses 0.47767 NCI Genomic Data 0.636969 Genomic Data Analysis 0.825105 Biospecimen Core Resource 0.713807	CLICK HERE